Joseph Epstein Centre for Emergency Medicine Research at Western Health, Sunshine Hospital, Melbourne, Victoria, Australia.
Eur J Emerg Med. 2013 Feb;20(1):54-7. doi: 10.1097/MEJ.0b013e32834fe934.
The aim of this study was to determine the prevalence and prognostic value of troponin elevation at emergency department (ED) presentation in patients admitted with an exacerbation of chronic obstructive pulmonary disease (COPD). A retrospective cohort study of ED patients with acute exacerbations of COPD who were admitted to hospital and in whom troponin was assayed at ED presentation. Other data collected included demographics, clinical characteristics, test results, and outcome. Outcome of interest was in-hospital mortality. A total of 252 patients were studied, median age 73 years, 61% men. In-hospital mortality was 4.4% [n=11; 95% confidence interval (CI) 2.5-7.7%]. Seventy-eight patients had elevated troponin of greater than 99th centile (31%, 95% CI 26-37%). Factors independently associated with mortality were troponin elevation [odds ratio (OR) 8.3, 95% CI 1.58-43.7], pH less than 7.2 (OR 12.7, 95% CI 1.86-86.4), and requirement for noninvasive ventilation (OR 8.09, 95% CI 1.61-40.8). In conclusion, troponin elevation is associated with increased in-hospital mortality in ED patients with acute exacerbation of COPD.
本研究旨在确定急诊科(ED)就诊的慢性阻塞性肺疾病(COPD)加重患者中肌钙蛋白升高的患病率和预后价值。这是一项回顾性队列研究,纳入了因 COPD 急性加重而住院并在 ED 就诊时检测肌钙蛋白的患者。收集的其他数据包括人口统计学、临床特征、检查结果和结局。研究的主要结局是院内死亡率。共纳入 252 例患者,中位年龄 73 岁,61%为男性。院内死亡率为 4.4%(n=11;95%置信区间为 2.5-7.7%)。78 例患者的肌钙蛋白高于第 99 百分位数(31%,95%置信区间为 26-37%)。与死亡率独立相关的因素包括肌钙蛋白升高(比值比[OR]8.3,95%置信区间为 1.58-43.7)、pH 值小于 7.2(OR 12.7,95%置信区间为 1.86-86.4)和需要无创通气(OR 8.09,95%置信区间为 1.61-40.8)。总之,ED 就诊的 COPD 急性加重患者肌钙蛋白升高与院内死亡率增加相关。